by Sumeet Singh | Mar 12, 2020 | California, State Regulation
AmerisourceBergen Reprimanded for Ineffective Suspicious Order Monitoring The settlement between the California Board of Pharmacy and AmerisourceBergen demonstrates the importance of embracing Suspicious Order Monitoring as a systematic and procedural Background The...
by Sumeet Singh | Feb 27, 2020 | Industry News, State Compliance Requirements, Telemedicine
How Telemedicine Has Made Generic Drugs Sexy Since 2017, Direct-to-Consumer (DTC) startups (some engaged by Pharma Solutions!) have cropped up to market and supply drugs to patients across the United States. The product portfolio is not too exciting – including...
by Sumeet Singh | Feb 20, 2020 | DEA, Federal Regulation
DEA SOM 2020 Updates Over two years in the making, the light at the end of the tunnel might finally be in sight – the Drug Enforcement Administration’s (DEA) has issued a Notice for Proposed Rule making as an update to the infamous definition of a “suspicious...
by Sumeet Singh | Jan 30, 2020 | Industry News
Consolidation is on the Horizon for 503Bs and WDDs The pharmaceutical industry has been notorious for consolidation and vertical integration over the last decade – and we can now expect another wave across two different business models. 503B Most of the content...
by Sumeet Singh | Dec 18, 2019 | Industry News
Pending Regulation on Drug Pricing Bernie Sanders and other top Democrats have made drug pricing a hot topic in US politics, especially with the election coming up next year. As such, there has been a flurry of bills and solutions to the perceived problem – and Drug...
